Kumpei Tokuyama Selected Research

Kumpei Tokuyama Research Topics

Disease

28	Insulin Resistance 03/2022 - 05/2002
8	Obesity 01/2019 - 06/2004
5	Type 2 Diabetes Mellitus (MODY) 03/2022 - 03/2011
5	Glucose Intolerance 01/2020 - 03/2007
4	Body Weight (Weight, Body) 03/2016 - 01/2009
3	Hyperglycemia 07/2019 - 06/2004
2	Inflammation (Inflammations) 01/2020 - 03/2007
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2014
2	Hyperinsulinism (Hyperinsulinemia) 11/2018 - 06/2004
2	Diabetes Mellitus 07/2012 - 12/2006
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2019
1	Disease Progression 07/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Weight Gain 07/2011
1	Fatty Liver 05/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2010
1	Neoplasms (Cancer) 01/2010
1	Hypoglycemia (Reactive Hypoglycemia) 04/2009
1	Hyperplasia 06/2004
1	Weight Loss (Weight Reduction) 04/2003
1	Pathologic Constriction (Stenosis) 05/2002
1	Carotid Stenosis (Carotid Artery Stenosis) 05/2002
1	Carotid Artery Diseases 05/2002

Drug/Important Bio-Agent (IBA)

21	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 10/2002
9	Insulin (Novolin)FDA Link 11/2016 - 02/2004
7	AdiponectinIBA 11/2013 - 04/2003
5	Triglycerides (Triacylglycerol)IBA 01/2019 - 05/2002
2	IsotopesIBA 03/2022 - 07/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2018
2	anagliptinIBA 11/2016 - 07/2013
2	LDL CholesterolIBA 05/2011 - 05/2002
2	AMP-Activated Protein KinasesIBA 01/2009 - 03/2006
2	LeptinIBA 07/2008 - 06/2004
2	ThiazolidinedionesIBA 03/2006 - 04/2003
2	LipidsIBA 05/2002 - 05/2002
1	Eicosapentaenoic AcidIBA 03/2022
1	Selenoprotein PIBA 03/2022
1	AntioxidantsIBA 01/2020
1	astaxanthine (astaxanthin)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 11/2019
1	Everolimus FDA Link 07/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	Arginine (L-Arginine)FDA Link 07/2019
1	Sirolimus (Rapamycin)FDA Link 07/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Co-Repressor ProteinsIBA 11/2018
1	Insulin ReceptorIBA 11/2018
1	CytokinesIBA 01/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2016
1	IncretinsIBA 11/2016
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 03/2016
1	AdipoRonIBA 11/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2013
1	GlucokinaseIBA 07/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2013
1	Blood Glucose (Blood Sugar)IBA 07/2012
1	Pyruvic Acid (Pyruvate)IBA 05/2011
1	Sterol Regulatory Element Binding Protein 1IBA 05/2011
1	CholesterolIBA 05/2011
1	Ezetimibe (Zetia)FDA Link 05/2011
1	Transaminases (Aminotransferases)IBA 05/2011
1	Glutamic Acid (Glutamate)FDA Link 05/2011
1	Bile Acids and Salts (Bile Acids)IBA 05/2011
1	EnzymesIBA 04/2010
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2010
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2010
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2009
1	RimonabantIBA 01/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2006
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2006
1	U 0126 (UO 126)IBA 09/2006
1	Pioglitazone (Actos)FDA Link 03/2006
1	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2004
1	Insulin Receptor Substrate ProteinsIBA 06/2004
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2004
1	Proteins (Proteins, Gene)FDA Link 04/2003
1	Nonesterified Fatty Acids (NEFA)IBA 05/2002
1	HDL CholesterolIBA 05/2002

Therapy/Procedure

2	Therapeutics 07/2019 - 04/2003
1	Glycemic Control 07/2019
1	Caloric Restriction 06/2004